{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T16:42:46Z","timestamp":1771000966900,"version":"3.50.1"},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1999,8]]},"DOI":"10.1093\/jac\/44.2.223","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T22:24:55Z","timestamp":1027722295000},"page":"223-228","source":"Crossref","is-referenced-by-count":15,"title":["In-vitro activity of dicationic aromatic compounds and fluconazole against Cryptococcus neoformans and Candida spp."],"prefix":"10.1093","volume":"44","author":[{"given":"Maurizio Del","family":"Poeta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy S.","family":"Bixel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Barchiesi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard R.","family":"Tidwell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Boykin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgio","family":"Scalise","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John R.","family":"Perfect","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[1999,8]]},"reference":[{"key":"key\n\t\t\t\t20170411034338_R1","doi-asserted-by":"crossref","unstructured":"Wheat, L. J. (1994). Fungal infections in the immunocompromised host. In Clinical Approach to Infection in the Compromised Host, (Rubin, R. H. & Young, L. S., Eds), pp. 211\u201337. Plenum, New York, NY.","DOI":"10.1007\/978-1-4615-2490-8_8"},{"key":"key\n\t\t\t\t20170411034338_R2","doi-asserted-by":"crossref","unstructured":"Cameron, M. L., Schell, W. A., Bruch, S., Bartlett, J. A., Waskin, H. A. & Perfect, J. R. (1993). Correlation of in-vitro fluconazole resistance of Candida isolates in relation to therapy and symptoms of individuals seropositive for human immunodeficiency virus type 1. Antimicrobial Agents and Chemotherapy3, 2449\u201353.","DOI":"10.1128\/AAC.37.11.2449"},{"key":"key\n\t\t\t\t20170411034338_R3","doi-asserted-by":"crossref","unstructured":"Fox, R., Neal, K. R., Leen, C. L. S., Ellis, M. E. & Mandal, B. K. (1991). Fluconazole resistant Candida in AIDS. Journal of Infection22, 201\u20134.","DOI":"10.1016\/0163-4453(91)91767-R"},{"key":"key\n\t\t\t\t20170411034338_R4","doi-asserted-by":"crossref","unstructured":"Pfaller, M. A., Rhine-Chalberg, A. J., Redding, S. W., Smith, J., Farinacci, G., Fothergill, A. W. et al. (1994). Variations in fluconazole susceptibility and electrophoretic karyotype among oral isolates of Candida albicans from AIDS and oral candidiasis. Journal of Clinical Microbiology32, 59\u201364.","DOI":"10.1128\/JCM.32.1.59-64.1994"},{"key":"key\n\t\t\t\t20170411034338_R5","doi-asserted-by":"crossref","unstructured":"Willocks, L., Leen, C. L. S., Brettle, R. P., Urquhart, D., Russel, T. B. & Milne, L. J. R. (1991). Fluconazole resistance in AIDS patients. Journal of Antimicrobial Chemotherapy28, 937\u20139.","DOI":"10.1093\/jac\/28.6.937"},{"key":"key\n\t\t\t\t20170411034338_R6","doi-asserted-by":"crossref","unstructured":"Bell, C. A., Cory, M., Fairley, T. A., Hall, J. E. & Tidwell, R. R. (1991). Structure\u2013activity relationships of pentamidine analogs against Giardia lamblia and correlation of antigiardial activity with DNA-binding affinity. Antimicrobial Agents and Chemotherapy35, 1099\u2013107.","DOI":"10.1128\/AAC.35.6.1099"},{"key":"key\n\t\t\t\t20170411034338_R7","doi-asserted-by":"crossref","unstructured":"Bell, C. A., Dykstra, C. C., Naiman, N. A., Cory, M., Fairley, T. A. & Tidwell, R. R. (1993). Structure\u2013activity studies of dicationically substituted bis-benzimidazoles against Giardia lamblia: correlation of antigiardial activity with DNA binding affinity and giardial topoisomerase II inhibition. Antimicrobial Agents and Chemotherapy37,2668\u2013 73.","DOI":"10.1128\/AAC.37.12.2668"},{"key":"key\n\t\t\t\t20170411034338_R8","doi-asserted-by":"crossref","unstructured":"Lindsay, D. S., Blagburn, B. L., Hall, J. E. & Tidwell, R. R. (1991). Activity of pentamidine and pentamidine analogs against Toxoplasma gondii in cell cultures. Antimicrobial Agents and Chemotherapy35, 1914\u20136.","DOI":"10.1128\/AAC.35.9.1914"},{"key":"key\n\t\t\t\t20170411034338_R9","doi-asserted-by":"crossref","unstructured":"Bell, C. A., Hall, J. E., Kyle, D. E., Grogl, M., Ohemeng, K. A., Allen, M. A. et al.(1990). Structure\u2013activity relationships of analogs of pentamidine against Plasmodium falciparum and Leishmania mexicana amazonensis.Antimicrobial Agents and Chemotherapy34, 1381\u20136.","DOI":"10.1128\/AAC.34.7.1381"},{"key":"key\n\t\t\t\t20170411034338_R10","unstructured":"Tidwell, R. R. & Bell, C. A. (1993). Pentamidine and related compounds in the treatment of Pneumocystis cariniiinfection. In Pentamidine and Related Compounds in the Treatment of Pneumocystis carinii Infection, (Walzer, P. D., Ed.), pp. 561\u201383. Marcel Dekker, New York, NY."},{"key":"key\n\t\t\t\t20170411034338_R11","doi-asserted-by":"crossref","unstructured":"Tidwell, R. R., Jones, S. K., Geratz, J. D., Ohemeng, K. A., Bell, C. A., Berger, B. J. et al. (1990). Development of pentamidine analogues as new agents for the treatment of Pneumocystis carinii pneumonia. Annals of the New York Academy of Sciences616, 421\u201341.","DOI":"10.1111\/j.1749-6632.1990.tb17862.x"},{"key":"key\n\t\t\t\t20170411034338_R12","doi-asserted-by":"crossref","unstructured":"Tidwell, R. R., Jones, S. K., Naiman, N. A., Berger, L. C., Brake, W. B., Dykstra, C. C. et al. (1993). Activity of cationically substituted bis-benzimidazoles against experimental Pneumocystis carinii pneumonia. Antimicrobial Agents and Chemotherapy37, 1713\u20136.","DOI":"10.1128\/AAC.37.8.1713"},{"key":"key\n\t\t\t\t20170411034338_R13","unstructured":"Keku, T. O., Seed, J. R. & Tidwell, R. R. (1995). The in-vitro HL-60 cell \u2013Trypanosoma brucei rhodesiense culture system: a rapid in-vitro drug screen. Tropical Medicine and Parasitology46, 258\u201362."},{"key":"key\n\t\t\t\t20170411034338_R14","doi-asserted-by":"crossref","unstructured":"Del Poeta, M., Schell, W. A., Dykstra, C. C., Jones, S. K., Tidwell, R. R., Czarny, A. et al. (1998). Structure\u2013in vitro activity relationships of pentamidine analogous and dication substituted bis-benzimidazoles as new antifungal agents. Antimicrobial Agents and Chemotherapy42, 2495\u2013502.","DOI":"10.1128\/AAC.42.10.2495"},{"key":"key\n\t\t\t\t20170411034338_R15","doi-asserted-by":"crossref","unstructured":"Del Poeta, M., Schell, W. A., Dykstra, C. C., Jones, S. K., Tidwell, R. R., Kumar, A., et al. (1998). In vitro antifungal activity of a series of dication substitute carbazoles, furans and benzimidazoles. Antimicrobial Agents and Chemotherapy42, 2503\u201310.","DOI":"10.1128\/AAC.42.10.2503"},{"key":"key\n\t\t\t\t20170411034338_R16","doi-asserted-by":"crossref","unstructured":"Boykin, D. W., Kumar, A., Spychala, J., Zhou, M., Lombardy, R. J., Wilson, W. D. et al. (1995). Dicationic diarylfurans as anti-Pneumocystis carinii agents. Journal of Medicinal Chemistry38, 912\u20136.","DOI":"10.1021\/jm00006a009"},{"key":"key\n\t\t\t\t20170411034338_R17","doi-asserted-by":"crossref","unstructured":"Barchiesi, F., Falconi Di Francesco, L., Compagnucci, P., Arzeni, D., Cirioni, O. & Scalise, G. (1997). Genotypic identification of sequential Candida albicans isolates from AIDS patients by Polymerase Chain Reaction techniques. European Journal of Clinical Microbiology and Infectious Diseases16, 601\u20135.","DOI":"10.1007\/BF02447925"},{"key":"key\n\t\t\t\t20170411034338_R18","doi-asserted-by":"crossref","unstructured":"White, T. C. (1997). Increased mRNA levels of ERG16,CDR, and MDR1 correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus. Antimicrobial Agents and Chemotherapy41, 1482\u20137.","DOI":"10.1128\/AAC.41.7.1482"},{"key":"key\n\t\t\t\t20170411034338_R19","doi-asserted-by":"crossref","unstructured":"White, T. C. (1997). The presence of an R467K amino acid substitution and loss of allelic variation correlate with azole-resistant lanosterol 14-a demethylase in Candida albicans.Antimicrobial Agents and Chemotherapy41, 1488\u201394.","DOI":"10.1128\/AAC.41.7.1488"},{"key":"key\n\t\t\t\t20170411034338_R20","unstructured":"National Committee for Clinical Laboratory Standards. (1997). Reference Method for Broth Dilution Susceptibility Testing of Yeasts: Accepted Standard M27-A. NCCLS, Wayne, PA."},{"key":"key\n\t\t\t\t20170411034338_R21","doi-asserted-by":"crossref","unstructured":"McGinnis, M. R. (1980). Susceptibility testing and bioassay procedure. In Laboratory Handbook of Medical Mycology, p. 431. Academic Press, New York, NY.","DOI":"10.1016\/B978-0-12-482850-6.50010-1"},{"key":"key\n\t\t\t\t20170411034338_R22","doi-asserted-by":"crossref","unstructured":"Boykin, D. W., Kumar Xiao, A. G., Wilson, W. D., Bender, B. C., McCurdy, D. R., Hall, J. E. et al. (1998). 2,5-Bis[4-(N-alkylamidino)phenyl]furans as anti-Pneumocystis carinii agents. Journal of Medicinal Chemistry41, 124\u20139.","DOI":"10.1021\/jm970570i"},{"key":"key\n\t\t\t\t20170411034338_R23","doi-asserted-by":"crossref","unstructured":"Blagburn, B. L., Sundermann, C. A., Lindsay, D. S., Hall, J. E. & Tidwell, R. R. (1991). Inhibition of Cryptosporidium parvum in neonatal Hsd: (ICR)BR Swiss mice by polyether ionophores and aromatic amidines. Antimicrobial Agents and Chemotherapy 35, 1520\u20133.","DOI":"10.1128\/AAC.35.7.1520"},{"key":"key\n\t\t\t\t20170411034338_R24","doi-asserted-by":"crossref","unstructured":"Dykstra, C. C., McClernon, D. R., Elwell, L. P. & Tidwell, R. R. (1994). Selective inhibition of topoisomerases from Pneumocystis carinii versus topoisomerases from mammalian cells. Antimicrobial Agents and Chemotherapy38, 1890\u20138.","DOI":"10.1128\/AAC.38.9.1890"},{"key":"key\n\t\t\t\t20170411034338_R25","doi-asserted-by":"crossref","unstructured":"Jones, S. K., Hall, J. E., Allen, M. A., Morrison, S. D., Ohemeng, K. A., Reddy, V. V. et al. (1990). Novel pentamidine analogs in the treatment of experimental Pneumocystis carinii pneumonia. Antimicrobial Agents and Chemotherapy3, 1026\u201330.","DOI":"10.1128\/AAC.34.6.1026"},{"key":"key\n\t\t\t\t20170411034338_R26","doi-asserted-by":"crossref","unstructured":"Del Poeta, M., Toffaletti, D. L., Rude, T. H., Dykstra, C. C., Heitman, J. & Perfect, J. R. (1999). Topoisomerase I is essential in Cryptococcus neoformans: role in pathobiology and as an antifungal target. Genetics152, 167\u201378.","DOI":"10.1093\/genetics\/152.1.167"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/44\/2\/223\/13057049\/JAC442223.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T15:58:58Z","timestamp":1621267138000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article-lookup\/doi\/10.1093\/jac\/44.2.223"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,8]]},"references-count":26,"journal-issue":{"issue":"2","published-online":{"date-parts":[[1999,8]]},"published-print":{"date-parts":[[1999,8]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/44.2.223","relation":{},"ISSN":["1460-2091","0305-7453"],"issn-type":[{"value":"1460-2091","type":"electronic"},{"value":"0305-7453","type":"print"}],"subject":[],"published":{"date-parts":[[1999,8]]}}}